Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The collagen receptor, discoidin domain receptor 2, functions in Gli1-positive skeletal progenitors and chondrocytes to control bone development. | Bone Res | 2022 | 35140200 | PubTator, text mining | PubMed |
| RNA sequencing on muscle biopsy from a 5-week bed rest study reveals the effect of exercise and potential interactions with dorsal root ganglion neurons. | Physiol Rep | 2022 | 35133080 | PubTator, text mining | PubMed |
| Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects. | Clin Transl Sci | 2022 | 35133064 | PubTator, text mining | PubMed |
| Matrix Vesicles as a Therapeutic Target for Vascular Calcification. | Front Cell Dev Biol | 2022 | 35127686 | PubTator, text mining | PubMed |
| A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. | Nat Cancer | 2022 | 35121989 | PubTator, text mining | PubMed |
| Identification and Validation of Novel Diagnostic Biomarkers for Keloid Based on GEO Database. | Int J Gen Med | 2022 | 35115816 | PubTator, text mining | PubMed |
| Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance. | Genes Chromosomes Cancer | 2022 | 35106856 | PubTator, text mining | PubMed |
| KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block. | Ther Adv Respir Dis | 2022 | 35098800 | PubTator, text mining | PubMed |
| Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma. | Cell Death Discov | 2022 | 35091546 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway. | Cell Oncol (Dordr) | 2022 | 35089546 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 2: A New Target in Cancer. | Oncol Res Treat | 2022 | 35073544 | PubTator, text mining | PubMed |
| In Silico Analysis of Collagens Missense SNPs and Human Abnormalities. | Biochem Genet | 2022 | 35066702 | PubTator, text mining | PubMed |
| Systematic review on the application of machine learning to quantitative structure-activity relationship modeling against Plasmodium falciparum. | Mol Divers | 2022 | 35064444 | PubTator, text mining | PubMed |
| Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19. | Viruses | 2022 | 35062298 | PubTator, text mining | PubMed |
| A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease. | Elife | 2022 | 35037854 | PubTator, text mining | PubMed |
| Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches. | Comput Biol Med | 2022 | 35032738 | PubTator, text mining | PubMed |
| Barring the gates to the battleground: DDR1 promotes immune exclusion in solid tumors. | Signal Transduct Target Ther | 2022 | 35027528 | PubTator, text mining | PubMed |
| Biobanking in dentistry: A review. | Jpn Dent Sci Rev | 2022 | 35024075 | PubTator, text mining | PubMed |
| Over-shedding of donor-derived cell-free DNA at immune-related regions into plasma of lung transplant recipient. | Clin Transl Med | 2022 | 35020272 | PubTator, text mining | PubMed |
| Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy. | Sci Rep | 2022 | 35013499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=38